Boryung's self medication projects impressive.

Published: 2007-03-19 06:57:00

Updated: 2007-03-19 06:57:00

Boryung announced on Jan. 1 this year that the OTC marketing division was renamed to the SM (self medication) division. Since then 2 month short term business performance of OTC products made a satisfactory achievement far beyond their target at 110%.

Astrix, an oral anti-platelet drug, showed...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK